| 摘要 |
This invention relates to a new strain of the genus Bifidobacterium and the components of its supernatants of cultivation in the form of various preparations (functional and new foods, probiotics, symbiotics, supplements, nutraceutics and medications) with the purpose of improving the defences and reducing the risk of disease. Its mechanisms of action include: (i) regulation of the intestinal glycosylation favouring that of healthy individuals, (ii) modulation of the interactions between the epithelial cells and the intestinal microbiotics, favouring the adhesion of beneficial bifidobacteria and (iii) regulation of the immunological responses. The products included are stable in gastrointestinal and technological conditions which guarantee their exploitation. |
